AUROPHARMABSEAurobindo Pharma LtdMediumNeutral
Announced Thu, 21 May · 20:53 IST

Intimation of resignation of MRR & Associates, Company Secretaries as secretarial auditor of the Company.

Auditor Resigned MidtermManagement Changes View source PDF

AUROPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-6.1%1-day move
₹1549.50
prior close
₹1520.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.6-2.0-2.6-2.6-6.1-5.9-7.6-8.2-7.3-7.4-9.4-3.5-1.1
Up moveDown movePending
AI summary

Aurobindo Pharma has announced a change in its secretarial auditor. M/s. MRR & Associates has resigned effective May 22, 2026, citing health issues of its sole proprietor as the reason. The company has simultaneously appointed M/s. RPR & Associates as the new secretarial auditor for a five-year term starting from FY 2026-27 to FY 2030-31, subject to shareholder approval at the ensuing AGM. RPR & Associates is a peer-reviewed firm with over 23 years of experience in corporate laws, SEBI regulations, and compliance audits, headed by Mr. Y. Ravi Prasada Reddy. The board meeting approving this change was held on May 21, 2026.

Likely market impact

The resignation of the secretarial auditor due to health reasons of the sole proprietor appears procedural in nature with minimal direct impact on shareholders. The company has promptly appointed a replacement, maintaining continuity in compliance and governance oversight.